Blair T. Stocks
Papers
1
Total Citations
4
H-Index
1
About
Blair T. Stocks is a clinical researcher whose work centers on the application of hyperbaric oxygen therapy (HBOT) to urological and sexual health conditions. His most notable contribution is a 2023 meta-analysis examining HBOT as a treatment for erectile dysfunction, which synthesized emerging evidence on the therapy’s potential to improve vascular function and tissue oxygenation. This study, with 4 citations, has helped spark renewed clinical interest in non-invasive, regenerative approaches to male sexual dysfunction. Stocks’ research bridges the gap between hyperbaric medicine and urology, highlighting how oxygen-based interventions may offer alternatives for patients who do not respond to conventional treatments. His work is particularly relevant for researchers exploring the vascular mechanisms underlying erectile dysfunction and the broader therapeutic applications of HBOT. By systematically evaluating existing data, Stocks has provided a foundation for future clinical trials and has contributed to a growing body of literature that positions HBOT as a promising, low-risk adjunct therapy. His scholarship reflects a commitment to evidence-based innovation in sexual medicine, making him a valuable voice for clinicians and scientists seeking to expand treatment options in this field.
Research Focus
Key Achievements
Top Papers
- 1